Share |

What Medical Technology exactly is

  • Brussels, 04 April 2011

    Safeguarding Europe’s healthcare systems for the future

    Innovation and research in medical technology provides Europeans with quick access to ever more efficient treatments which not only benefit people, but also contributes to a sustainable, competitive society. Recognising this, the European Commission organised for the second time the Innovation in Healthcare conference and invited Eucomed to showcase the innovative nature of the medical technology industry.
    read more
  • Brussels, 22 March 2011

    Enabling European medical technology SMEs to innovate

    A survey among twelve national medical technology industry associations in Europe identified four significant barriers that confront SMEs at EU level in their strive for innovation. The barriers are related to consistent application of EU regulation, regulation inhibiting novel technology commercialisation, access to R&D funding programmes and access to distribution channels. Strengthening and developing EU policies that support innovation among SME’s is part of the ‘Europe 2020 Strategy’ and Eucomed, the European medical technology industry association, requests the European Commission to work together with the industry in removing these barriers and to jointly conduct a more comprehensive in-depth survey among medical technology SMEs to clarify and target their needs in detail.
    read more
  • Brussels, 28 February 2011

    A modern approach in demonstrating the value of medical technology

    To better explain the role medical technology plays in enabling people to live healthy and productive lives, in increasing the productivity and efficiency of health systems, and in contributing to economic growth in Europe, Eucomed today unveiled its overhauled website www.eucomed.org. The website relaunch marks the first step in a series of efforts being undertaken by the European Medical Technology Industry Association.
    read more
  • 25 February 2011

    European Commission objects to FDA remarks in a letter

    25 February 2011 - According to Reuters: “A transatlantic spat has erupted after a top U.S. official suggested European patients may be "guinea pigs" for medical devices with less government oversight. A senior official at the European Commission, in a letter obtained by Reuters, complained to the U.S. Food and Drug Administration this month about comments from the FDA's device chief, Dr. Jeffrey Shuren.....” For the full story please go to the Reuters website
    read more
  • Brussels, 03 February 2011

    Eucomed submits 4 proposals to Innovation Union

    Innovation within the European medical technology industry not only increases competitiveness, but also actively improves EU citizens’ well-being. However, certain barriers to innovation still exist today which prevent Europe’s innovative potential from being used to the fullest. Wanting to improve European competitiveness while tackling societal challenges, the European Commission (EC) in October 2010 launched the Innovation Union Strategy, of which the pilot Innovation Partnership on Active and Healthy Ageing is a key component. Eucomed, the European Medical Technology Industry Association, believes that the medical technology industry is uniquely positioned to contribute to these goals by continuing to drive the competitiveness and sustainability of Europe.
    read more